Literature DB >> 4303951

Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.

J van der Veen, M F Abarbanel, K G Oei.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4303951      PMCID： PMC2130674          DOI： 10.1017/s0022172400028242

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN： 0022-1724


× No keyword cloud information.
  8 in total

1.  II. EFFICACY OF ADJUVANT AND AQUEOUS ADENOVIRUS VACCINES IN PREVENTION OF NAVAL RECRUIT RESPIRATORY DISEASE.

Authors:  L F MILLER; R O PECKINPAUGH; T R ARLANDER; W E PIERCE; E A EDWARDS; P DEBERRY; I A PHILLIPS; M J ROSENBAUM
Journal:  Am J Public Health Nations Health       Date:  1965-01

2.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

3.  Epidemiology of adenovirus respiratory infections in military recruit populations.

Authors:  M R HILLEMAN
Journal:  Ann N Y Acad Sci       Date:  1957-04-19       Impact factor: 5.691

4.  Homotypic and heterotypic antibody response in infants to adenovirus vaccine.

Authors:  J van der Veen; D J van Zaane; M A Sprangers; C F Heyen
Journal:  Arch Gesamte Virusforsch       Date:  1967

5.  Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection.

Authors:  R R Gutekunst; R J White; W P Edmondson; R M Chanock
Journal:  Am J Epidemiol       Date:  1967-09       Impact factor: 4.897

6.  Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers.

Authors:  R M Chanock; W Ludwig; R J Heubner; T R Cate; L W Chu
Journal:  JAMA       Date:  1966-02-07       Impact factor: 56.272

7.  Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease.

Authors:  W P Edmondson; R H Purcell; B F Gundelfinger; J W Love; W Ludwig; R M Chanock
Journal:  JAMA       Date:  1966-02-07       Impact factor: 56.272

8.  Inactivation of adenovirus and simian virus 40 tumorigenicity in hamsters by vaccine processing methods.

Authors:  G T Truffelli; E A Timm; W B Beardmore; I W McLean
Journal:  Appl Microbiol       Date:  1967-05
  8 in total
  5 in total

1.  Patterns of infections with adenovirus types 4, 7 and 21 in military recruits during a 9-year survey.

Authors:  J van der Veen; K G Oei; M F Abarbanel
Journal:  J Hyg (Lond)       Date:  1969-06

2.  Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004.

Authors:  Kevin L Russell; Anthony W Hawksworth; Margaret A K Ryan; Jennifer Strickler; Marina Irvine; Christian J Hansen; Gregory C Gray; Joel C Gaydos
Journal:  Vaccine       Date:  2006-01-24       Impact factor: 3.641

3.  Adenovirus Type 4 Respiratory Infections among Civilian Adults, Northeastern United States, 2011-20151.

Authors:  Adriana E Kajon; Daryl M Lamson; Camden R Bair; Xiaoyan Lu; Marie L Landry; Marilyn Menegus; Dean D Erdman; Kirsten St George
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

4.  Live Oral Adenovirus Type 4 and Type 7 Vaccine Induces Durable Antibody Response.

Authors:  Natalie D Collins; Anima Adhikari; Yu Yang; Robert A Kuschner; Nicos Karasavvas; Leonard N Binn; Shannon D Walls; Paul C F Graf; Christopher A Myers; Richard G Jarman; Jun Hang
Journal:  Vaccines (Basel)       Date:  2020-07-23

5.  To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia.

Authors:  Maha Othman; Alexander T Baker; Elena Gupalo; Abdelrahman Elsebaie; Carly M Bliss; Matthew T Rondina; David Lillicrap; Alan L Parker
Journal:  J Thromb Haemost       Date:  2021-08-23       Impact factor: 16.036
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.